In this prespecified interim analysis, atrasentan resulted in a significant and clinically meaningful reduction in proteinuria as compared with placebo in patients with IgA nephropathy. (Funded by Novartis; ALIGN ClinicalTrials.gov number, NCT04573478.).
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
风吹麦田
大力的灵雁
dew
无糖加冰
tiptip
Zzz
Zac
殷勤的紫槐
乐观秋荷
昏睡的蟠桃
pluto
乐空思
这杯酒名忘情
畔畔
lizishu
Alexa
你嵙这个期刊没买
ySX
微尘
皖公网安备34019202002308